KERYX BIOPHARMACEUTICALS INC 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed May 27, 2016
Insider Transaction Report
Form 4
Regan Daniel Paul
Director
Transactions
- Award
Stock Options (right to buy)
2016-05-26+30,000→ 30,000 totalExercise: $5.71From: 2017-05-26Exp: 2026-05-26→ Common Stock (30,000 underlying) - Award
Common Stock
2016-05-26+10,000→ 40,000 total
Footnotes (3)
- [F1]The 10,000 shares are restricted common stock, with one-third of the 10,000 shares vesting on each of May 26, 2017, May 26, 2018 and May 26, 2019.
- [F2]Includes 23,998 shares of restricted stock.
- [F3]The 30,000 stock options vest as to one-third on each of May 26, 2017, May 26, 2018 and May 26, 2019.